Close Menu

Tekmira

Tekmira Pharmaceuticals this week unveiled new preclinical data from its Ebola and Marburg virus programs, showing that its siRNA-based therapies were effective in non-human primates even when treatment was delayed by as much as 48 hours after infection.

Tekmira Pharmaceuticals this week said that the underwriters of its recent public stock offering of 3.75 million shares have exercised their over-allotment option to buy an additional 562,000 shares at $8 apiece.

Title: Methods and Compositions Involving microRNA
Patent Number: 8,568,971
Filed: Sept. 24, 2010
Lead Inventor: David Brown, Asuragen

RNAi drugs startup Arcturus Therapeutics this week announced that it has raised $5 million in a Series A round of financing, which comes just months after the company pulled in $1.5 million in seed money.

Tekmira Pharmaceuticals this week announced the release of preclinical data showing that its lipid nanoparticles can be used to deliver messenger RNA into the liver, tumors, and other tissues in vivo.

Tekmira Pharmaceuticals this week announced that it has completed the public offering of $30 million of its common stock.

Tekmira Pharmaceuticals said this week that it has priced a public offering of 3.75 million shares of its common stock at $8 a share, for gross proceeds of $30 million.
Tekmira stock closed at $8.82 on Wednesday.

Tekmira Pharmaceuticals this week announced that it has added hepatitis B to its pipeline, and that it anticipates filing an investigational new drug application for the program in 2014.

Tekmira Pharmaceuticals has appointed Bruce Cousins as its new CFO.
Cousins previously served in various roles at Aspreva Pharmaceuticals, Johnson & Johnson, and Deloitte & Touche.

Less than a month after publishing data showing that siRNAs formulated in its lipid nanoparticles could provide 100 percent post-exposure protection against Marburg virus infection in guinea pigs, Tekmira Pharmaceuticals has announced similar findings in non-human primates.

Pages

The Hill reports President Donald Trump issued an executive directing federal agencies to cut the number of board and advisory committees they have.

The New York Times reports that researchers are combining tools to more quickly develop crops to feed a growing population and cope with shifting climates.

Scientists in Canada are looking to the UK's plan to sequence children with rare conditions for inspiration, the National Post reports.

In PNAS this week: copy number changes arose during polar bear evolution, genomic and transcriptomic analysis of the Siberian hamster, and more.